Charles River Laboratories International Inc
Charles River Laboratories Intern.../ US1598641074 /
CRL
|
2024-05-07 10:10:00 PM
|
Chg.
+1.03
|
Volume |
Bid2:10:21 PM |
Ask2:10:21 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
236.30USD
|
+0.44%
|
473,892
Turnover: 63.48 mill. |
210.00Bid Size: 600 |
259.98Ask Size: 200 |
12.13 bill.USD |
- |
25.49 |
Business description
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Its employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
Management board & Supervisory board
| CEO |
| James C. Foster |
| Management board |
| Flavia Pease, William D. Barbo, Victoria L. Creamer, Birgit Girshick, Joseph W. LaPlume, Shannon M. Parisotto, Brian Bathgate, Ph.D., Matthew L. Daniel, Kerstin Dolph, Colin S. Dunn, Ph.D., Kristen M. Eisenhauer, Professor Julie Frearson, Ph.D., Wilbert Frieling, D.V.M., E.R.T., John C. Ho, M.D., Foster T. Jordan, Michael G. Knell, Mark Mintz, Gina M. Mullane, Barbara J. Patterson |
| Supervisory board |
| James C. Foster, Nancy C. Andrews M.D., Ph.D., Robert J. Bertolini, Deborah T. Kochevar, D.V.M., Ph.D., D.A.C.V.C.P., George Llado, Martin Mackay, Ph.D., George E. Massaro, C. Richard Reese, Craig B. Thompson, M.D., Richard F. Wallman, Virginia M. (Gina) Wilson |
Company data
| Name: |
Charles River Laboratories International, Inc. |
| Address: |
251 Ballardvale Street,Wilmington, Massachusetts 01887, USA |
| Phone: |
+1-781-222-6000 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.criver.com |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
88.30% |
| IPO date: |
2000-06-23 |
Company calendar
|
CW 19 | 2024-05-09
Interim Report 1st Quarter/3 Months
|
